Contact
searchSearch
HMP Global

PharmLaw Basic Listing

PharmLaw
Wholesale Pharmaceutical Executives Sentenced in $92 Million Drug Diversion Scheme
03/18/2026
Grace Taylor, MS, MA
Two wholesale pharmaceutical executives were sentenced in a large-scale drug diversion case that raised concerns about medication safety and supply chain integrity.
Two wholesale pharmaceutical executives were sentenced in a large-scale drug diversion case that raised concerns about medication safety and supply chain integrity.
Two wholesale pharmaceutical...
03/18/2026
Pharmacy Learning Network
PharmLaw
Novo Nordisk Drops Patent Suit as Hims & Hers Shifts to FDA-Approved Semaglutide Products
03/11/2026
Hannah Musick
Novo Nordisk has dropped its patent lawsuit against Hims & Hers after the telehealth company agreed to stop promoting compounded GLP-1 products and instead offer US Food and Drug Administration (FDA)-approved Ozempic and Wegovy at established...
Novo Nordisk has dropped its patent lawsuit against Hims & Hers after the telehealth company agreed to stop promoting compounded GLP-1 products and instead offer US Food and Drug Administration (FDA)-approved Ozempic and Wegovy at established...
Novo Nordisk has dropped its...
03/11/2026
Pharmacy Learning Network
PharmLaw
Louisiana Secures $45M Settlement With CVS, Caremark Over PBM Practices
03/04/2026
Grace Taylor, MS, MA
Louisiana secured a $45 million settlement from CVS and its pharmacy benefit manager (PBM) affiliate following lawsuits alleging deceptive practices, misuse of patient data, and anti-competitive conduct affecting independent pharmacies.
Louisiana secured a $45 million settlement from CVS and its pharmacy benefit manager (PBM) affiliate following lawsuits alleging deceptive practices, misuse of patient data, and anti-competitive conduct affecting independent pharmacies.
Louisiana secured a $45 million...
03/04/2026
Pharmacy Learning Network
PharmLaw
Federal Court Preliminarily Approves $5.275M Settlement in PharMerica Data Breach Class Action
02/27/2026
Grace Taylor, MS, MA
A federal judge has preliminarily approved a $5.275 million nationwide settlement resolving claims that PharMerica failed to safeguard patient data in a 2023 ransomware attack.
A federal judge has preliminarily approved a $5.275 million nationwide settlement resolving claims that PharMerica failed to safeguard patient data in a 2023 ransomware attack.
A federal judge has...
02/27/2026
Pharmacy Learning Network
PharmLaw
Physician Sentenced in $145 Million Compound Cream Kickback Scheme Involving DOL-OWCP Billing
02/25/2026
Grace Taylor, MS, MA
A Texas physician was sentenced to prison for accepting kickbacks tied to medically unnecessary compounded creams billed to the US Department of Labor’s Office of Workers’ Compensation Programs (DOL-OWCP) and private insurers.
A Texas physician was sentenced to prison for accepting kickbacks tied to medically unnecessary compounded creams billed to the US Department of Labor’s Office of Workers’ Compensation Programs (DOL-OWCP) and private insurers.
A Texas physician was sentenced...
02/25/2026
Pharmacy Learning Network
PharmLaw
Atlantic Biologicals Enters Deferred Prosecution Agreement in Opioid Distribution Scheme
02/18/2026
Hannah Musick
Atlantic Biologicals Corporation has entered a 2-year deferred prosecution agreement after admitting its business unit sold more than 14 million opioid doses to Houston-area pill mill pharmacies, generating over $2.5 million in gross proceeds.
Atlantic Biologicals Corporation has entered a 2-year deferred prosecution agreement after admitting its business unit sold more than 14 million opioid doses to Houston-area pill mill pharmacies, generating over $2.5 million in gross proceeds.
Atlantic Biologicals Corporation...
02/18/2026
Pharmacy Learning Network
PharmLaw
Two Queens Men Charged in $120 Million Medicare and Medicaid Pharmacy and Adult Day Care Fraud Scheme
02/17/2026
Hannah Musick
Federal prosecutors have charged 2 Queens men with conspiracy to commit health care fraud, alleging a $120 million scheme involving illegal kickbacks, bribes, and fraudulent pharmacy and adult day care claims billed to Medicare and Medicaid.
Federal prosecutors have charged 2 Queens men with conspiracy to commit health care fraud, alleging a $120 million scheme involving illegal kickbacks, bribes, and fraudulent pharmacy and adult day care claims billed to Medicare and Medicaid.
Federal prosecutors have charged...
02/17/2026
Pharmacy Learning Network
PharmLaw
Novo Nordisk Sues Hims & Hers as FDA Moves to Restrict Compounded GLP-1 Drugs
02/10/2026
Juliet Gallagher
Novo Nordisk has escalated its fight against compounded semaglutide products by filing a patent infringement lawsuit against Hims & Hers Health, while the US Food and Drug Administration (FDA) announced sweeping enforcement actions aimed at...
Novo Nordisk has escalated its fight against compounded semaglutide products by filing a patent infringement lawsuit against Hims & Hers Health, while the US Food and Drug Administration (FDA) announced sweeping enforcement actions aimed at...
Novo Nordisk has escalated its...
02/10/2026
Pharmacy Learning Network
PharmLaw
Iowa Attorney General Accuses Insulin Makers and PBMs of Deceptive Pricing Practices
02/03/2026
Juliet Gallagher
Iowa Attorney General Brenna Bird has filed a sweeping lawsuit against major insulin manufacturers and pharmacy benefit managers (PBMs), alleging a coordinated, years-long scheme to artificially inflate the prices of insulin and other...
Iowa Attorney General Brenna Bird has filed a sweeping lawsuit against major insulin manufacturers and pharmacy benefit managers (PBMs), alleging a coordinated, years-long scheme to artificially inflate the prices of insulin and other...
Iowa Attorney General Brenna...
02/03/2026
Pharmacy Learning Network
PharmLaw
PCMA Sues California Over SB 41, Challenging PBM Fiduciary Duties Under ERISA
01/27/2026
Juliet Gallagher
California’s most ambitious pharmacy benefit manager (PBM) reform effort has drawn an immediate legal challenge, as the Pharmaceutical Care Management Association (PCMA) filed a federal lawsuit contesting key provisions of Senate Bill 41 (SB...
California’s most ambitious pharmacy benefit manager (PBM) reform effort has drawn an immediate legal challenge, as the Pharmaceutical Care Management Association (PCMA) filed a federal lawsuit contesting key provisions of Senate Bill 41 (SB...
California’s most ambitious...
01/27/2026
Pharmacy Learning Network
Breaking News
News
Expert Perspectives
Commentary

FDA Drug Recalls

News
Bottles of Children’s Ibuprofen Recalled Nationwide Over Contamination Concerns
03/19/2026
Grace Taylor, MS, MA
A nationwide recall of children’s ibuprofen oral suspension has been initiated after reports of foreign material, including gel-like masses and black particles, were found in affected bottles.
A nationwide recall of children’s ibuprofen oral suspension has been initiated after reports of foreign material, including gel-like masses and black particles, were found in affected bottles.
A nationwide recall of...
03/19/2026
Pharmacy Learning Network
News
FDA Class III Recall Issued for Pitavastatin Tablets Due to Mixed Dosage Tablet in Bottle
03/19/2026
Grace Taylor, MS, MA
A nationwide alert has been issued after a mislabeled bottle of pitavastatin was found to contain a lower-dose tablet, prompting a Class III recall affecting select inventory in Tennessee.
A nationwide alert has been issued after a mislabeled bottle of pitavastatin was found to contain a lower-dose tablet, prompting a Class III recall affecting select inventory in Tennessee.
A nationwide alert has been...
03/19/2026
Pharmacy Learning Network
News
Apotex Recalls Brimonidine/Timolol Ophthalmic Solution Over Sterility Concerns
03/19/2026
Grace Taylor, MS, MA
Apotex has voluntarily recalled over 100 000 vials of brimonidine/timolol ophthalmic solution distributed nationwide due to concerns about lack of sterility.
Apotex has voluntarily recalled over 100 000 vials of brimonidine/timolol ophthalmic solution distributed nationwide due to concerns about lack of sterility.
Apotex has voluntarily recalled...
03/19/2026
Pharmacy Learning Network
News
Midodrine Hydrochloride Under Class II Recall Due to Inadequately Sealed Blister Packaging
03/12/2026
Hannah Musick
The Harvard Drug Group LLC is recalling one lot of midodrine hydrochloride tablets nationwide due to inadequately sealed blister packaging that may compromise product integrity.
The Harvard Drug Group LLC is recalling one lot of midodrine hydrochloride tablets nationwide due to inadequately sealed blister packaging that may compromise product integrity.
The Harvard Drug Group LLC is...
03/12/2026
Pharmacy Learning Network
News
Teva Metoprolol Succinate Tablets Recalled for Failed Dissolution Specifications
03/12/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for multiple strengths of Teva’s metoprolol succinate extended-release tablets due to failed dissolution specifications, potentially affecting consistent cardiovascular...
The US Food and Drug Administration (FDA) has issued a Class II recall for multiple strengths of Teva’s metoprolol succinate extended-release tablets due to failed dissolution specifications, potentially affecting consistent cardiovascular...
The US Food and Drug...
03/12/2026
Pharmacy Learning Network

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use